AdventHealth

• Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity

  Phase 4, Enrolling by invitation, 300 people, 6 Aug 2026

• A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer

  Active, not recruiting, 64 people, 13 Aug 2025

• NCT04245397

  Collaborator, Phase 1, Recruiting, 151 people, 28 Jan 2020

• NCT03576885

  Phase 1/2, Terminated, 32 people, 3 Jul 2018

• NCT02449369

  Phase 4, Completed, 180 people, 20 May 2015

• NCT02215265

  Collaborator, Phase 3, Active, not recruiting, 1,269 people, 13 Aug 2014

• NCT02039115

  Phase 4, Terminated, 3 people, 17 Jan 2014

• NCT02025634

  Phase 4, Completed, 119 people, 1 Jan 2014

Sources: clinicaltrials.gov

• University of Maryland Baltimore

  Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibito (sub-award to UNIVERSITY OF MARYLAND, BALTIMORE), usaspending_subaward/ASST_NON_U01DK143384_075/Z9CRZKD42ZT1, US$53.2k, 2026, 15 Apr 2026

• University of California-irvine

  Investigating the role of adipose tissue in mobility and aging (SOMMA-AT) (sub-award to UNIVERSITY OF CALIFORNIA IRVINE), usaspending_subaward/ASST_NON_R01AG066474_075/MJC5FCYQTPE6, US$38.1k, 2025, 24 Feb 2025

Sources: openalex.org

• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

  Fees or honoraria, 20 Aug 2021

• Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis

  Consulting or advice, Fees or honoraria, Grants or research support, 1 Feb 2021

Sources: pubmed.ncbi.nlm.nih.gov